Medicare Enrolled
Dr. Alla Sakharova, M.D.
Endocrinology · Berkley, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sakharova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sakharova?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sakharova
Dr. Alla Sakharova is an endocrinology specialist in Berkley, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sakharova performed 2,368 Medicare services across 1,357 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sakharova received a total of $11,503 from 63 pharmaceutical and/or device companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sakharova is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in MI
$11,503 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,368
Medicare services
Top 13% in MI for endocrinology
1,357
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~125 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
641 | $93 | $140 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
515 | $40 | $70 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
302 | $27 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
287 | $126 | $205 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
237 | $63 | $115 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
91 | $136 | $280 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
57 | $3 | $5 |
| New patient office visit, complex (60-74 min) | 48 | $164 | $295 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
26 | $8 | $50 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
25 | $16 | $50 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
25 | $108 | $225 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
23 | $10 | $150 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
23 | $7 | $35 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
20 | $12 | $70 |
| Hemoglobin analysis by chromatography A laboratory test that uses chromatography to separate and measure different types of hemoglobin in the blood. |
17 | $17 | $35 |
| Thyroid needle biopsy A procedure in which a thin needle is inserted through the skin into the thyroid gland to remove a small sample of tissue for examination. |
16 | $42 | $205 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
15 | $98 | $190 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,503
Total received (2018-2024)
Avg $1,643/year across 7 years
Top 22% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
728
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,503 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,910
2023
$2,287
2022
$2,393
2021
$1,517
2020
$967
2019
$546
2018
$883
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$465
Amgen Inc.
$361
Medtronic, Inc.
$328
Novo Nordisk Inc
$267
Boehringer Ingelheim Pharmaceuticals, Inc.
$184
Bayer Healthcare Pharmaceuticals Inc.
$165
Dexcom, Inc.
$148
ABBVIE INC.
$113
SANOFI-AVENTIS U.S. LLC
$89
Abbott Laboratories
$84
Insulet Corporation
$79
Corcept Therapeutics
$69
Tolmar, Inc.
$59
Amphastar Pharmaceuticals, Inc.
$58
Neurocrine Biosciences, Inc.
$54
Esperion Therapeutics, Inc.
$47
Astellas Pharma US Inc
$45
Tandem Diabetes Care, Inc.
$41
Mannkind Corporation
$34
Xeris Pharmaceuticals, Inc.
$34
Amneal Pharmaceuticals LLC
$22
Alvogen Inc
$21
RECORDATI_RARE_DISEASES_INC.
$20
Alexion Pharmaceuticals, Inc.
$19
PFIZER INC.
$19
Ascensia Diabetes Care Us Inc.
$17
CeQur Corporation
$16
TheracosBio, LLC
$15
Verity Pharmaceuticals Inc.
$15
Acella Pharmaceuticals, LLC
$14
BETA BIONICS, INC.
$9
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,748
Novo Nordisk Inc
$1,504
Dexcom, Inc.
$655
Amgen Inc.
$627
Boehringer Ingelheim Pharmaceuticals, Inc.
$585
SANOFI-AVENTIS U.S. LLC
$552
Medtronic, Inc.
$530
AstraZeneca Pharmaceuticals LP
$392
Bayer Healthcare Pharmaceuticals Inc.
$373
Abbott Laboratories
$353
Corcept Therapeutics
$283
Insulet Corporation
$243
Amneal Pharmaceuticals LLC
$183
DEXCOM, INC.
$182
Radius Health, Inc.
$176
Mannkind Corporation
$175
ABBVIE INC.
$173
Tandem Diabetes Care, Inc.
$160
Alvogen Inc
$158
Ascendis Pharma Inc
$152
Bayer HealthCare Pharmaceuticals Inc.
$125
Xeris Pharmaceuticals, Inc.
$116
Merck Sharp & Dohme Corporation
$112
AbbVie Inc.
$110
Alexion Pharmaceuticals, Inc.
$101
Medtronic MiniMed, Inc.
$93
Janssen Pharmaceuticals, Inc
$88
RECORDATI_RARE_DISEASES_INC.
$85
LifeScan, Inc.
$85
Becton, Dickinson and Company
$81
Antares Pharma, Inc.
$79
Astellas Pharma US Inc
$71
IBSA Pharma Inc.
$67
Amarin Pharma Inc.
$66
LIFESCAN, INC.
$65
Horizon Therapeutics plc
$64
MannKind Corporation
$60
Tolmar, Inc.
$59
PFIZER INC.
$59
Amphastar Pharmaceuticals, Inc.
$58
Neurocrine Biosciences, Inc.
$54
Esperion Therapeutics, Inc.
$47
Supernus Pharmaceuticals, Inc.
$46
EUSA Pharma (US) LLC
$45
Ipsen Biopharmaceuticals, Inc
$45
CeQur Corporation
$45
AbbVie, Inc.
$43
VistaPharm, Inc.
$42
Ultragenyx Pharmaceutical Inc.
$41
Embecta Corp.
$33
Amryt Pharma Holdings Ltd
$33
Ascensia Diabetes Care US Inc.
$22
Zealand Pharma US, Inc.
$18
Ascensia Diabetes Care Us Inc.
$17
Acerus Pharmaceuticals Corporation
$16
Clarus Therapeutics Inc.
$15
Aytu BioScience, Inc
$15
TheracosBio, LLC
$15
Verity Pharmaceuticals Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Acella Pharmaceuticals, LLC
$14
GRT US Holding, Inc.
$12
BETA BIONICS, INC.
$9
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ASCENDA · Androgel · BAQSIMI · BD Nano 2nd Gen Pen Needle · BELSOMRA · BYETTA · Brenzavvy · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ELIGARD · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · Prolia · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Veozah · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
82
Per 100K population
6.4
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sakharova is a clinical cardiology specialist, with above-average Medicare volume (top 13% in MI), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sakharova experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sakharova performed 641 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sakharova receive payments from pharmaceutical companies?
Yes. Dr. Sakharova received a total of $11,503 from 63 companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sakharova's costs compare to other endocrinologists in Berkley?
Dr. Sakharova's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sakharova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Berkley
Browse endocrinologists in Berkley ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Dexcom, Inc. Payments to Doctors
See all physicians who received payments from Dexcom, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology